New strategies for the treatment of clear cell renal cell carcinoma:target the metabolic reprogramming
10.3760/cma.j.issn.1673-422X.2019.07.012
- VernacularTitle:肾透明细胞癌的治疗新策略:靶向代谢重编程
- Author:
Liang CHEN
1
;
Min PENG
;
Yiming WENG
;
Qibin SONG
Author Information
1. 武汉大学人民医院肿瘤中心 430060
- Keywords:
Kidney neoplasms;
Metabolic networks and pathways;
Therapy
- From:
Journal of International Oncology
2019;46(7):443-446
- CountryChina
- Language:Chinese
-
Abstract:
For the last decade,the incidence of kidney neoplasms has shown an obvious rising trend in the world. The most common histopathological type of kidney neoplasms is clear cell renal cell carcinoma (ccRCC),which has a poor prognosis. ccRCC is generally accompanied by reprogramming of glucose,fatty acid,glutamine,tryptophan and arginine metabolic networks and pathways. Reprogramming of metabolic net-works and pathways enables tumor cells to proliferate rapidly,survive in conditions of nutrient depletion and hy-poxia,and escape surveillance by epidemic systems. New strategies have been developed to the treatment of ccRCC by targeting key proteins or enzymes involved in metabolic reprogramming pathways.
